SK284193B6 - Prostriedok na podávanie biologicky účinnej látky, zabezpečujúci jej pomalé uvoľňovanie, jeho použitie a farmaceutický prostriedok s jeho obsahom - Google Patents
Prostriedok na podávanie biologicky účinnej látky, zabezpečujúci jej pomalé uvoľňovanie, jeho použitie a farmaceutický prostriedok s jeho obsahom Download PDFInfo
- Publication number
- SK284193B6 SK284193B6 SK1642-98A SK164298A SK284193B6 SK 284193 B6 SK284193 B6 SK 284193B6 SK 164298 A SK164298 A SK 164298A SK 284193 B6 SK284193 B6 SK 284193B6
- Authority
- SK
- Slovakia
- Prior art keywords
- silica
- xerogel
- biologically active
- active agent
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0015—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0031—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
- A61L24/0042—Materials resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/02—Surgical adhesives or cements; Adhesives for colostomy devices containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/10—Ceramics or glasses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01B—NON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
- C01B33/00—Silicon; Compounds thereof
- C01B33/113—Silicon oxides; Hydrates thereof
- C01B33/12—Silica; Hydrates thereof, e.g. lepidoic silicic acid
- C01B33/16—Preparation of silica xerogels
- C01B33/163—Preparation of silica xerogels by hydrolysis of organosilicon compounds, e.g. ethyl orthosilicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/43—Hormones, e.g. dexamethasone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Surgery (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Ceramic Engineering (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Silicon Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1857596P | 1996-05-29 | 1996-05-29 | |
US4242397P | 1997-03-27 | 1997-03-27 | |
PCT/FI1997/000330 WO1997045367A1 (en) | 1996-05-29 | 1997-05-29 | Dissolvable oxides for biological applications |
Publications (2)
Publication Number | Publication Date |
---|---|
SK164298A3 SK164298A3 (en) | 1999-11-08 |
SK284193B6 true SK284193B6 (sk) | 2004-10-05 |
Family
ID=26691266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1642-98A SK284193B6 (sk) | 1996-05-29 | 1997-05-29 | Prostriedok na podávanie biologicky účinnej látky, zabezpečujúci jej pomalé uvoľňovanie, jeho použitie a farmaceutický prostriedok s jeho obsahom |
Country Status (18)
Country | Link |
---|---|
EP (2) | EP0906243B2 (de) |
JP (1) | JP4322315B2 (de) |
CN (1) | CN1103320C (de) |
AT (1) | ATE301102T1 (de) |
AU (1) | AU738176B2 (de) |
CA (1) | CA2257172C (de) |
CZ (1) | CZ297042B6 (de) |
DE (1) | DE69733889T3 (de) |
DK (1) | DK0906243T4 (de) |
EE (1) | EE03758B1 (de) |
ES (1) | ES2244998T5 (de) |
HU (1) | HU227939B1 (de) |
NO (1) | NO328711B1 (de) |
NZ (1) | NZ332968A (de) |
PL (1) | PL330191A1 (de) |
RU (1) | RU2208582C2 (de) |
SK (1) | SK284193B6 (de) |
WO (1) | WO1997045367A1 (de) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI980032A0 (fi) * | 1998-01-09 | 1998-01-09 | Heikki Matti Eemeli Rauvala | Ny anvaendning av en heparin bindande, med tillvaext foerknippad molekyl |
FI109332B (fi) * | 1998-12-17 | 2002-07-15 | Orion Yhtymae Oyj | Toremifeenin liukoisia koostumuksia |
US6395299B1 (en) | 1999-02-12 | 2002-05-28 | Biostream, Inc. | Matrices for drug delivery and methods for making and using the same |
CZ20012748A3 (cs) * | 1999-02-22 | 2002-03-13 | Bioxid Oy | Způsob výroby řízeně biodegradovatelných keramických vláken z hydrosolu kysličníku křemičitého |
FI19991806A (fi) * | 1999-08-25 | 2001-02-26 | Yli Urpo Antti | Uusia koostumuksia biologisesti aktiivisen aineen säädettyyn vapauttamiseen, ja niiden valmistus |
US6632412B2 (en) * | 1999-12-01 | 2003-10-14 | Timo Peltola | Bioactive sol-gel derived silica fibers and methods for their preparation |
AUPQ573300A0 (en) * | 2000-02-21 | 2000-03-16 | Australian Nuclear Science & Technology Organisation | Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
US7758888B2 (en) | 2000-04-21 | 2010-07-20 | Sol-Gel Technologies Ltd. | Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
EP1335693A2 (de) | 2000-04-21 | 2003-08-20 | Sol-Gel Technologies Ltd. | Zusammensetzung mit erhöhter formulationsstabilität und verabreichung von topischen wirkstoffen |
WO2002080977A1 (en) * | 2001-04-04 | 2002-10-17 | Delsitech Oy | Biodegradable carrier and method for preparation thereof |
JP4199545B2 (ja) * | 2001-04-27 | 2008-12-17 | ビボキシド オサケユイチア | 軟組織付着の改善方法、および移植片作製のための該方法の使用 |
WO2005007802A2 (en) * | 2002-03-15 | 2005-01-27 | The Trustees Of The University Of Pennsylvania | Fibrous composite for tissue engineering |
EP1675570B1 (de) * | 2003-01-24 | 2016-12-14 | The Research Foundation Of State University Of New York | Nanoteilchen auf keramikbasis zum einschliessen von therapeutischen mitteln für die photodynamische therapie und anwendungsverfahren dafür |
EP1656199B1 (de) | 2003-07-31 | 2016-01-06 | Sol-Gel Technologies Ltd. | Mikrokapseln, die aktive stoffe enthalten sowie sein herstellungsverfahren |
KR20070001145A (ko) | 2004-02-27 | 2007-01-03 | 델시테크 오와이 | 조정가능한 생체 재흡수성의 졸-겔 유도 이산화규소를제조하기 위한 방법 |
GB0420016D0 (en) | 2004-09-09 | 2004-10-13 | Leuven K U Res & Dev | Controlled release oral delivery system |
JP4006002B2 (ja) * | 2004-11-26 | 2007-11-14 | キヤノン株式会社 | Dna担持繊維及びdna担持繊維シート並びにこれらの製造方法 |
EP2431088A1 (de) | 2005-08-02 | 2012-03-21 | Sol-Gel Technologies Ltd. | Metalloxidbeschichtung von wasserunlöslichen Inhaltsstoffen |
EP1942731A2 (de) | 2005-09-27 | 2008-07-16 | Sol-Gel Technologies Ltd. | Pflanzenschutzverfahren |
US8450105B2 (en) | 2006-05-04 | 2013-05-28 | Agency For Science, Technology And Research | Mechanically reversible gel |
EP2020987B1 (de) * | 2006-06-06 | 2013-10-30 | Universidad Autónoma Metropolitana | Sol-gel-nanostrukturierte titandioxid-reservoirs zur verwendung bei der kontrollierten freisetzung von arzneimitteln im zentralen nervensystem und syntheseverfahren |
JP2010505883A (ja) | 2006-10-12 | 2010-02-25 | ザ ユニバーシティー オブ クイーンズランド | 免疫応答を調節するための組成物および方法 |
DE102007061873A1 (de) * | 2007-01-15 | 2008-07-17 | Bayer Innovation Gmbh | Kieselsol-Material zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien dessen Herstellung und Verwendung |
FI20070174A0 (fi) * | 2007-02-28 | 2007-02-28 | Delsitech Oy | Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt |
JP5344417B2 (ja) * | 2007-04-17 | 2013-11-20 | 国立大学法人群馬大学 | 水油界面を利用した薬物−シリカ封入体の製造法 |
DE102007026043B4 (de) * | 2007-06-04 | 2018-08-16 | Jiangsu Synecoun Medical Technology Co., Ltd. | Nicht-toxisches Polyethoxysiloxan-Material zur Herstellung von biologisch resorbierbares und/oder bioaktives Polyethoxysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung |
DE102007061874A1 (de) * | 2007-12-19 | 2009-06-25 | Bayer Innovation Gmbh | Nicht-toxisches Polysiloxan-Material zur Herstellung von biologisch resorbierbaren und/oder bioaktiven Polysiloxan-Material enthaltenden Artikeln, dessen Herstellung und Verwendung |
DE102008033327A1 (de) * | 2008-07-16 | 2010-01-21 | Bayer Innovation Gmbh | Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik |
DE102009053782A1 (de) * | 2009-11-19 | 2011-06-01 | BSH Bosch und Siemens Hausgeräte GmbH | Poröses SiO2-Xerogel mit charakteristischer Porengröße, dessen trocknungsstabile Vorstufen und dessen Anwendung |
DE102009053784A1 (de) * | 2009-11-19 | 2011-05-26 | BSH Bosch und Siemens Hausgeräte GmbH | Verfahren zur Herstellung eines porösen SiO2-Xerogels mit charakteristischer Porengröße durch ein Bottom-Up-Verfahren über eine Vorstufe mit organischen Festkörperskelettstützen |
US8901185B2 (en) * | 2010-04-12 | 2014-12-02 | Universite Claude Bernard Lyon I | Hybrid organic-inorganic material constituted by a silica network having photochromic agents and optical power limiting agents as a doping agent in the material |
EP2417982A1 (de) * | 2010-07-30 | 2012-02-15 | Ferring B.V. | Stabilisierung von Gonadotropinen |
DE102010034695A1 (de) * | 2010-08-18 | 2012-02-23 | Gesellschaft zur Förderung von Medizin-, Bio- und Umwelttechnologien e.V. | Xerogele mit homogen eingebetteten Lebensmittelzusätzen und Verfahren zur ihrer Herstellung |
WO2012058715A1 (en) | 2010-11-01 | 2012-05-10 | University Of Technology, Sydney | Immune-modulating agents and uses therefor |
AU2012352528B9 (en) | 2011-12-11 | 2017-11-02 | Baudax Bio, Inc. | Intranasal dexmedetomidine compositions and methods of use thereof |
WO2014078435A1 (en) | 2012-11-14 | 2014-05-22 | W. R. Grace & Co.-Conn. | Compositions containing a biologically active material and a non-ordered inorganic oxide |
US9687465B2 (en) | 2012-11-27 | 2017-06-27 | Sol-Gel Technologies Ltd. | Compositions for the treatment of rosacea |
JP6433490B2 (ja) * | 2013-06-24 | 2018-12-05 | デルシテク オサケ ユキチュア | シリカハイドロゲルコンポジット |
CN104546804A (zh) * | 2013-10-09 | 2015-04-29 | 上海现代药物制剂工程研究中心有限公司 | 三维网状立体构型的透皮给药制剂及其制备方法 |
CN108367076B (zh) | 2015-10-22 | 2021-08-31 | 德尔科技有限公司 | 水凝胶复合材料药性持久制剂 |
GR1010001B (el) * | 2019-12-30 | 2021-05-12 | Πυρογενεσις Αβεε | Υδρογελες και ξηρογελες φορεις δραστικων συστατικων αποτελουμενες απο δενδριτικα πολυμερη και πυριτια για εφαρμογες επικαλυψης σε στερεα υποστρωματα |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3846537A (en) * | 1972-08-21 | 1974-11-05 | Monsanto Co | Process of preparing silica xerogels |
JPH0764543B2 (ja) * | 1987-07-24 | 1995-07-12 | 富士デヴィソン化学株式会社 | 球状シリカ及びその製法 |
IT1216570B (it) * | 1988-04-08 | 1990-03-08 | Vectorpharma Int | Composizione farmaceutiche a rilascio controllato e procedimento per la loro preparazione. |
US5200334A (en) * | 1991-08-13 | 1993-04-06 | The Regents Of The University Of California | Sol-gel encapsulated enzyme |
DE4422912A1 (de) * | 1994-06-30 | 1996-01-11 | Hoechst Ag | Xerogele, Verfahren zu ihrer Herstellung, sowie ihre Verwendung |
US5591453A (en) * | 1994-07-27 | 1997-01-07 | The Trustees Of The University Of Pennsylvania | Incorporation of biologically active molecules into bioactive glasses |
-
1997
- 1997-05-29 AT AT97924045T patent/ATE301102T1/de active
- 1997-05-29 WO PCT/FI1997/000330 patent/WO1997045367A1/en active IP Right Grant
- 1997-05-29 NZ NZ332968A patent/NZ332968A/xx not_active IP Right Cessation
- 1997-05-29 EE EE9800418A patent/EE03758B1/xx unknown
- 1997-05-29 JP JP54169197A patent/JP4322315B2/ja not_active Expired - Lifetime
- 1997-05-29 EP EP97924045A patent/EP0906243B2/de not_active Expired - Lifetime
- 1997-05-29 DE DE69733889T patent/DE69733889T3/de not_active Expired - Lifetime
- 1997-05-29 ES ES97924045T patent/ES2244998T5/es not_active Expired - Lifetime
- 1997-05-29 RU RU98123591/12A patent/RU2208582C2/ru not_active IP Right Cessation
- 1997-05-29 CZ CZ0384598A patent/CZ297042B6/cs not_active IP Right Cessation
- 1997-05-29 AU AU29641/97A patent/AU738176B2/en not_active Ceased
- 1997-05-29 EP EP05101502A patent/EP1618896A3/de not_active Withdrawn
- 1997-05-29 HU HU9903865A patent/HU227939B1/hu not_active IP Right Cessation
- 1997-05-29 CA CA002257172A patent/CA2257172C/en not_active Expired - Fee Related
- 1997-05-29 DK DK97924045T patent/DK0906243T4/da active
- 1997-05-29 SK SK1642-98A patent/SK284193B6/sk not_active IP Right Cessation
- 1997-05-29 PL PL97330191A patent/PL330191A1/xx unknown
- 1997-05-29 CN CN97195027A patent/CN1103320C/zh not_active Expired - Lifetime
-
1998
- 1998-11-27 NO NO19985534A patent/NO328711B1/no not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK284193B6 (sk) | Prostriedok na podávanie biologicky účinnej látky, zabezpečujúci jej pomalé uvoľňovanie, jeho použitie a farmaceutický prostriedok s jeho obsahom | |
US7326422B2 (en) | Dissolvable oxides for biological applications | |
US20040121451A1 (en) | Treatment of sols, gels and mixtures thereof | |
Radin et al. | In vivo tissue response to resorbable silica xerogels as controlled-release materials | |
JP5646849B2 (ja) | 有マクロ孔性および高い吸収性を有するアパタイト型リン酸カルシウムセメント | |
Yin et al. | Preparation and characterization of macroporous chitosan–gelatin/β‐tricalcium phosphate composite scaffolds for bone tissue engineering | |
Kortesuo et al. | Sol‐gel‐processed sintered silica xerogel as a carrier in controlled drug delivery | |
EP2403547B1 (de) | Produktion eines formbaren knochensubstituts | |
WO2003088925A2 (en) | Method of manufacturing hydroxyapatite and uses therefor in delivery of nucleic acids | |
JPH05504941A (ja) | 歯周組織の再生のための生体分解系 | |
US10149825B2 (en) | Method for preparing adjustably bioresorbable sol-gel derived SiO2 | |
JP4932992B2 (ja) | シリカゾルからの生分解性セラミック繊維 | |
Chen et al. | Preparation of recombinant human bone morphogenetic protein-2 loaded dextran-based microspheres and their characteristics | |
Qu et al. | 4.428. Sol-Gel Processed Oxide Controlled Release Materials | |
KR101685295B1 (ko) | 다중 약물 탑재 스캐폴드 및 이의 용도 | |
KR100262142B1 (ko) | 치주조직재생용약물함유생분해성차폐막및그의제조방법 | |
CN108704142B (zh) | 一种生物降解高分子药物缓释材料及其制备方法 | |
EP1368071A1 (de) | Behandlung von sols, gels, gemischen oder zusammensetzungen aus sols und gels, und/oder materialien aus sols und gels |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4A | Expiry of patent |
Expiry date: 20170529 |